1. Crosstalk between Beclin-1-dependent autophagy and caspase-dependent apoptosis induced by tanshinone IIA in human osteosarcoma MG-63 cells
   Kun Ma et al, 2016 CrossRef
2. STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line
   Hoda Soleymani Abyaneh et al, 2017, Cancers CrossRef
3. Phytotherapy and Nutritional Supplements on Breast Cancer.
   C M Lopes et al, 2017, Biomed Res Int CrossRef
4. Role of phytochemicals in the inhibition of epithelial–mesenchymal transition in cancer metastasis
   Eun-Kyung Kim et al, 2016, Food Funct. CrossRef
5. TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters
   Kun Li et al, 2017, Biomedicine & Pharmacotherapy CrossRef
6. Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB
   YANGQIU BAI et al, 2016 CrossRef
7. Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α
   Jiang Qian et al, 2018, BioMed Research International CrossRef
8. Ferrous glycinate regulates cell energy metabolism by restrictinghypoxia-induced factor-1α expression in human A549 cells
   Yung-Ting Kuo et al, 2018, Free Radical Research CrossRef
9. Current Report of Natural Product Development against Breast Cancer Stem Cells
   Adam Hermawan et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
10. Tanshinone II A improves distribution and anti-tumor efficacy of pegylated liposomal doxorubicin via normalizing the structure and function of tumor vasculature in hepa1-6 hepatoma mice model
    Zhang Ying et al, 2018, Journal of Traditional Chinese Medicine CrossRef
11. Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction
    Sheng-Teng Huang et al, 2017, Sci. Rep. CrossRef
12. Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal 18F-FES PET/CT
    SiMin He et al, 2019, Contrast Media & Molecular Imaging CrossRef
13. Dual Effects of Chinese Herbal Medicines on Angiogenesis in Cancer and Ischemic Stroke Treatments: Role of HIF-1 Network
    Ming Hong et al, 2019, Front. Pharmacol. CrossRef
14. Expression of Hypoxia-inducible Factor Prolyl Hydroxylase 3 HIFPH3 in Human Non-small Cell Lung Cancer (NSCLC) and Its Correlation with Prognosis
    Xiao Chu et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
15. Multiple pro-apoptotic targets of abietane diterpenoids from Salvia species
    M. Akaberi et al, 2015, Fitoterapia CrossRef
16. Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells
    Xin Wang et al, 2015, Anti-Cancer Drugs CrossRef
17. Phytochemical and biological research of Salvia medicinal resources
    Da Cheng Hao et al, 2015 CrossRef
18. Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
    Yu-Shih Lin et al, 2019, Front. Pharmacol. CrossRef
19. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis
    Ying Jiang et al, 2019, International Immunopharmacology CrossRef
20. Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
    Devarajan Nalini et al, 2019, J Cancer Res Clin Oncol CrossRef
21. Metabolite profiling of traditional Chinese medicine XIAOPI formula: An integrated strategy based on UPLC-Q-Orbitrap MS combined with network pharmacology analysis
    Neng Wang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
22. Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells
    Jui-Wen Ma et al, 2016, Oncotarget CrossRef
23. Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases
    Zhibei Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
24. Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
    Xiaozhong Liao et al, 2020, Front. Oncol. CrossRef
25. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
    Dimas Carolina Belisario et al, 2020, Cells CrossRef
26. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
    Muhlis Akman et al, 2021, J Exp Clin Cancer Res CrossRef
27. Tanshinone IIA: A Review of its Anticancer Effects
    Zhong‐ying Fang et al, 2021, Front. Pharmacol. CrossRef
28. Tanshinone ⅡA inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition and protects bovine endometrial epithelial cells from pyolysin-induced damage by modulating the NF-κB/Snail2 signaling pathway
    Kaiqiang Fu et al, 2021, Theriogenology CrossRef
29. Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer
    Zhou Jin et al, 2022, Front. Pharmacol. CrossRef
30. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.
    Wenfeng Zhang et al, 2022, Am J Chin Med CrossRef
31. Salvia miltiorrhiza in Breast Cancer Treatment: A Review of Its Phytochemistry, Derivatives, Nanoparticles, and Potential Mechanisms
    Huan Zhao et al, 2022, Front. Pharmacol. CrossRef
32. Dihydrotanshinone I Enhances Cell Adhesion and Inhibits Cell Migration in Osteosarcoma U−2 OS Cells through CD44 and Chemokine Signaling
    Lanyan Fan et al, 2022, Molecules CrossRef
33. Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance
    Sruthi Sritharan et al, 2022, Apoptosis CrossRef
34. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis
    Tingrui Ge et al, 2022 CrossRef
35. Tanshinone IIA regulates expression of glucose transporter 1 via activation of the HIF‑1α signaling pathway
    Yanyun Zhou et al, 2022, Mol Med Rep CrossRef
36. Recent Advances (2015–2020) in Drug Discovery for Attenuation of Pulmonary Fibrosis and COPD
    Atukuri Dorababu et al, 2023, Molecules CrossRef
37. Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks
    Sepideh Mirzaei et al, 2023, Pathology - Research and Practice CrossRef
38. Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms
    Jiayan Huang et al, 2023, Journal of Ethnopharmacology CrossRef
39. Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer
    Na Luo et al, 2024, Journal of Advanced Research CrossRef